配色: 字号:
Prognostic Value of Cytologic Parameters in.pdf
2020-10-19 | 阅:  转:  |  分享 
  
1532CANCERAprilI1984Vol.53
13.GolombHM,VardimanJ.RowleyJD.Acutenonlymphocyticcytosinearabinoside,6-thioguanineandpyrimethamineforthetreatment
ofacutenon-lymphoblasticleukemia.C''uwcvTrm/Rep1976;60:4I-
leukemiainadults:Correlationswitha-bandedchromosomes.B/fJod
53.
1976;48:9-2I.
14.BennettJM.CatovskyD,DanielMTc/a/.Proposalsforthe26.CurrieG.Prognosissignificanceofserumlysozymeinadultacute
classificationoftheacuteleukaemias.BrJffucvna/o/1976:33:451-myelogenousleukemia.Lanexi/1976:1335-837.
458.27.HendersonES,WallaceJY,ScharlawCe/(I/.Factorsinfluencing
15.BurnsCP,ArmitageJO.FreyAL.DickFR.JordanJE,Woolsonprognosisinadultacutemyelocyticleukemia.In:AdvancesintheBio-
RF.Analysisofthepresentingfeaturesofadultacuteleukemia:Thesciences14:WorkshoponPrognosticFactorsinHumanAcuteLeukemia.
French-American-Britishclassification.(hni.c,rI981:47:2460-2469.NewYork:Pergamon.1975:71-82.
16.MertelsmannR.ThalerHT.ToL(''Ia/.Morphologicalclassifi-28.TobelemG.JacquillatC,ChastangCYIa/.Acutemonoblastic
cation.responsetotherapyandsurvivalin263adultpatientswithacuteleukemia:Aclinicalandbiologicalstudyof74cases.Blood1980;55:
nonlymphoblasticleukemia.B/ootl1980;56;773-78I.71-76,
17.BernardJ.WeilM,BoironM,JacquillatC.FlandrinG.Gemon29.ZittounR,CadiouM.Facquet-DankJ.ZittounJ,Bilski-Pasquier
MF.Acutepromyelocyticleukemia:Resultsoftreatmentbydauno-G.ClassificationcytologiquedesleucemiesaiguesdeI''adulte.l''uthol
rubicin.Blood1973:4I:489-496.Bid1976;24:469-475.
18.EllisonRR.HollandJF.WeilMe/id.Arabinosylcytosine;A30.MarieJP.PerrotJY.BoucheixC(''Ia/.Determinationofultra-
usefulagentinthetreatmentofascuteleukemiainadults.B/ofJd1968:structuralperoxidasesandimmunologicmembranemarkersinthedi-
32:507-523.agnosisofacuteleukemias.Blood1982;59:270-276.
19.KaplanEL.MeierP.Nonparametricestimationfromincomplete3I,CurtisJE.TillJE,MessnerHA,SousanP.McCullochEA.Com-
observations.J.4uicr9tr/:ls.soc~1958:53:457-481.parisonofoutcomesandprognosticfactorsfortwogroupsofpatients
withacutemyeloblasticleukemia.LcitkRcJs1979;3:409-416.
20.PikeMC.ArmitageP,BreslowNEc''/ulDesignandanalysisof
32.FreiE111.HartJS.Cytokineticstudiesandtreatmentresponse
randomizedclinicaltrialsrequiringprolongedobservationofeachpatient:
inadultacuteleukemia.In:RecentResultsinCancerResearchNo-
11Analysisandexamples.BrJ(''untw1977;35:l-39.
menclature.MethodologyandResultsofClinicalTrialsinAcuteLeu-
21.AfifiAA.AzenSP.StatisticalAnalysis:AComputerOriented
kemias.Berlin:Springer-Verlag.1973;81-87,
Approach.ed.2.NewYork:AcademicPress,1979.
33.HartJS,GeorgeSL.FreiEe/ul.Prognosticsignificanceofpre-
22.KendallM.RankCorrelationMethods,ed.4.London:Charles
treatmentproliferativeactivityinadultleukemia.Cunccr1977:39:I103-
GriHinandCoLtd..1975.
1617.
23.DickFR.ArmitageJO.BurnsCP.Diagnosticconcurrenceinthe
34.ZittounR.DieboldJ,GorinN.Leucemiesaiguesavecmyklo-
subclassificationofadultacuteleukemiausingFrench-American-British
fibrose.NoirvRe,\FrHfniurol1972;12:229-24O.
criteria.Ihticw1982:49:916-920.
35.TulliezM.Breton-GoriusJ.ThreetypesofAuerbodiesinacute
24.SultanC.DeregnancourtJ.KOYWt''/d.Distributionof250
leukemia:visualisationoftheirproteinbynegativecontrastafterper-
casesofacutemyeloidleukaemia(AML)accordingtotheFABclas-
oxidasecytochemistry.LahI,ivec/1979;41:419-426.
sificationandresponsetotherapy.BrJIluc,~nulo/1981:47:545-55I.
36.SultanC.Heilmann-GouaultM.TulliezM.Relationshipbetween
25.WiernikP.SchimpffS.SchifferC(''Ia/.Randomizedclinicalblast-cellmorphologyandoccurrenceofasyndromeofdisseminated
comparisonofdaunorubicinalonewithacomparisonofdaunorubicin,intravascularcoagulation.BrJtlucwurol1973;24:255-259.
献花(0)
+1
(本文系丽丽661首藏)